Based on this YouTube video's total view count of 173K views and industry-standard rates, the estimated total earning is $122 - $347 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore Understand Risks of GLP-1s | Dr. Chris Thompson & Dr. Andrew Huberman with 173,674 views, 633 likes, and 118 comments. Experience the impact of this video content that has captured audience attention.

Chris Thompson and Dr. Andrew Huberman discuss why so many people quit GLP-1 drugs, how microdosing can reduce nausea and maintain weight loss, and the muscle loss risk of cycling on and off. Dr. Chris Thompson, MD, Professor of Medicine at Harvard Medical School, Chief of Interventional Gastroenterology at Mass General Brigham in Boston, and Co-Director of the Center for Weight Management and Wellness, is a world-renowned expert on gastroenterology, metabolism, nutrition, and obesity medicine. Dr. Andrew Huberman is a tenured professor of neurobiology and ophthalmology at Stanford University School of Medicine and host of the Huberman Lab podcast. Watch the full episode: https://youtu.be/ecjEM3NJ0lU?si=nuZsmDmMG_gtox8k Show notes: https://go.hubermanlab.com/moMYULJ *Timestamps* 00:00 Why People Quit GLP-1s 02:39 Microdosing GLP-1s 04:46 Muscle Loss & Cycling Off 06:06 Resistance Training & Muscle 06:48 Apathy, Blindness & Real Side Effects #HubermanLab #ChrisThompson #GLP-1s Disclaimer & Disclosures: https://www.hubermanlab.com/disclaimer

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.